RxDoctor Payments DataLook up a doctor →

Timothy West, MD

Neurology · Salt Lake City, UTNPI 1861650731

Payments from drug & device makers

$889,007in general payments, 2019–2025

Across 931 payments — averaging $954.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$403K
  • EMD Serono, Inc.$209K
  • TG Therapeutics, Inc.$111K
  • Novartis$89K
  • Sanofi$42K
  • Genentech USA, Inc.$17K
  • plus $18K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen303$402,629
EMD Serono, Inc.224$209,100
TG Therapeutics, Inc.114$111,277
Novartis96$88,739
Sanofi51$42,019
Genentech USA, Inc.45$17,321
Amgen(2 entities)16$7,917
Novartis Pharma AG2$6,916
Bristol Myers Squibb8$1,189
Ares Trading SA1$660
AstraZeneca7$120
Banner Life Sciences, LLC7$115
Mallinckrodt Enterprises LLC10$108
CSL Behring4$80
Sunovion Pharmaceuticals Inc.4$68
Sanofi-aventis U.S. LLC1$65
ANI Pharmaceuticals, Inc.3$60
Pfizer3$58
UCB, Inc.2$51
Teva Pharmaceuticals USA, Inc.3$47
Argenx US, Inc.2$45
AbbVie(2 entities)3$42
Biohaven Pharmaceuticals, Inc.2$35
Axsome Therapeutics, Inc.2$35
Lundbeck LLC2$32
Jazz Pharmaceuticals Inc.2$32
Merz Pharmaceuticals, LLC1$24
Catalyst Pharmaceuticals, Inc.1$23
Octapharma USA, Inc.1$23
Biohaven Pharmaceutical Holding Company Ltd.1$22
Akcea Therapeutics, Inc.1$20
Medtronic1$20
Supernus Pharmaceuticals, Inc.1$16
Acorda Therapeutics, Inc1$16
Abbott1$15
Lilly USA, LLC1$15
E.r. Squibb & Sons, L.L.C.1$15
Johnson & Johnson1$15
Mallinckrodt Hospital Products Inc.1$13
Neurelis, Inc.1$12

How this compares

$889,007 in reported general payments places this provider in the 90th percentile of 157 neurology providers in Utah.

See all neurology providers in Utah →

Medicare billing

Part B allowed, 2024
$102,516
Medicare patients
45
Services billed
4,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →